Global Glucagon Competitive Landscape Professional Research Report 2025
Description
Global Glucagon Competitive Landscape Professional Research Report 2025
Research Summary
Glucagon is a peptide hormone produced by the alpha cells of the pancreas, and it plays a crucial role in regulating blood glucose levels in the body. It acts in opposition to insulin, promoting the release of glucose from the liver into the bloodstream (glycogenolysis) and stimulating the conversion of other substrates into glucose (gluconeogenesis). Glucagon acts primarily in response to low blood sugar levels, signaling the liver to release stored glucose to elevate blood glucose levels, ensuring a steady supply of energy for the body. This hormone is vital in maintaining glucose homeostasis, and an imbalance in the insulin-glucagon axis can contribute to conditions such as diabetes. In clinical settings, synthetic glucagon is sometimes administered to raise blood sugar levels in emergency situations, such as severe hypoglycemia, where rapid glucose mobilization is necessary.
According to DIResearch's in-depth investigation and research, the global Glucagon market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Glucagon include Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Xeris Pharmaceuticals, Taj Pharmaceuticals etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Glucagon. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Glucagon market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Glucagon market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Glucagon industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Glucagon Include:
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Xeris Pharmaceuticals
Taj Pharmaceuticals
Glucagon Product Segment Include:
Inject Glucagon
Nasal Glucagon
Glucagon Product Application Include:
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Glucagon Industry PESTEL Analysis
Chapter 3: Global Glucagon Industry Porter’s Five Forces Analysis
Chapter 4: Global Glucagon Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Glucagon Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Glucagon Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Glucagon Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Glucagon Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Glucagon Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Glucagon Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Glucagon Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Glucagon Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Glucagon Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Glucagon Product by Type
- 1.2.1 Inject Glucagon
- 1.2.2 Nasal Glucagon
- 1.3 Glucagon Product by Application
- 1.3.1 Emergency Kits
- 1.3.2 General Use
- 1.3.3 Diagnostic & Motility
- 1.3.4 Cardiogenic Shock
- 1.3.5 Others
- 1.4 Global Glucagon Market Revenue and Sales Analysis
- 1.4.1 Global Glucagon Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Glucagon Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Glucagon Market Sales Price Trend Analysis (2020-2032)
- 1.5 Glucagon Industry Trends and Innovation
- 1.5.1 Glucagon Industry Trends and Innovation
- 1.5.2 Glucagon Market Drivers and Challenges
- 2 Glucagon Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Glucagon Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Glucagon Market Analysis by Regions
- 4.1 Glucagon Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Glucagon Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Glucagon Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Glucagon Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Glucagon Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Glucagon Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Glucagon Sales Forecast by Region (2026-2032)
- 4.4 Global Glucagon Sales Price Trend Analysis (2020-2032)
- 5 Global Glucagon Market Size by Type and Application
- 5.1 Global Glucagon Market Size by Type
- 5.1.1 Global Glucagon Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Glucagon Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Glucagon Market Size by Application
- 5.2.1 Global Glucagon Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Glucagon Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Glucagon Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Glucagon Market Size by Type
- 6.3.1 North America Glucagon Sales by Type (2020-2032)
- 6.3.2 North America Glucagon Revenue by Type (2020-2032)
- 6.4 North America Glucagon Market Size by Application
- 6.4.1 North America Glucagon Sales by Application (2020-2032)
- 6.4.2 North America Glucagon Revenue by Application (2020-2032)
- 6.5 North America Glucagon Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Glucagon Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Glucagon Market Size by Type
- 7.3.1 Europe Glucagon Sales by Type (2020-2032)
- 7.3.2 Europe Glucagon Revenue by Type (2020-2032)
- 7.4 Europe Glucagon Market Size by Application
- 7.4.1 Europe Glucagon Sales by Application (2020-2032)
- 7.4.2 Europe Glucagon Revenue by Application (2020-2032)
- 7.5 Europe Glucagon Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Glucagon Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Glucagon Market Size by Type
- 8.3.1 China Glucagon Sales by Type (2020-2032)
- 8.3.2 China Glucagon Revenue by Type (2020-2032)
- 8.4 China Glucagon Market Size by Application
- 8.4.1 China Glucagon Sales by Application (2020-2032)
- 8.4.2 China Glucagon Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Glucagon Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Glucagon Market Size by Type
- 9.3.1 APAC (excl. China) Glucagon Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Glucagon Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Glucagon Market Size by Application
- 9.4.1 APAC (excl. China) Glucagon Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Glucagon Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Glucagon Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Glucagon Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Glucagon Market Size by Type
- 10.3.1 Latin America Glucagon Sales by Type (2020-2032)
- 10.3.2 Latin America Glucagon Revenue by Type (2020-2032)
- 10.4 Latin America Glucagon Market Size by Application
- 10.4.1 Latin America Glucagon Sales by Application (2020-2032)
- 10.4.2 Latin America Glucagon Revenue by Application (2020-2032)
- 10.5 Latin America Glucagon Market Size by Country
- 10.6 Latin America Glucagon Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Glucagon Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Glucagon Market Size by Type
- 11.3.1 Middle East & Africa Glucagon Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Glucagon Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Glucagon Market Size by Application
- 11.4.1 Middle East & Africa Glucagon Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Glucagon Revenue by Application (2020-2032)
- 11.5 Middle East Glucagon Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Glucagon Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Glucagon Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Glucagon Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Glucagon Average Sales Price by Manufacturers (2021-2025)
- 12.2 Glucagon Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Glucagon Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Novo Nordisk
- 13.1.1 Novo Nordisk Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Novo Nordisk Glucagon Product Portfolio
- 13.1.3 Novo Nordisk Glucagon Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 Eli Lilly
- 13.2.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Eli Lilly Glucagon Product Portfolio
- 13.2.3 Eli Lilly Glucagon Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 Fresenius Kabi
- 13.3.1 Fresenius Kabi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Fresenius Kabi Glucagon Product Portfolio
- 13.3.3 Fresenius Kabi Glucagon Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 Torrent Labs
- 13.4.1 Torrent Labs Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Torrent Labs Glucagon Product Portfolio
- 13.4.3 Torrent Labs Glucagon Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 Xeris Pharmaceuticals
- 13.5.1 Xeris Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Xeris Pharmaceuticals Glucagon Product Portfolio
- 13.5.3 Xeris Pharmaceuticals Glucagon Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.6 Taj Pharmaceuticals
- 13.6.1 Taj Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Taj Pharmaceuticals Glucagon Product Portfolio
- 13.6.3 Taj Pharmaceuticals Glucagon Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Glucagon Industry Chain Analysis
- 14.2 Glucagon Industry Raw Material and Suppliers Analysis
- 14.2.1 Glucagon Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Glucagon Typical Downstream Customers
- 14.4 Glucagon Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
